Gene · 2074
Papers2,375
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,375
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unlocking Zenith Electronic State of Ni Sites in Ligand-Engineered COFs for Efficient •O2 --Driven Uranium Photoreduction. | Adv Sci (Weinh) | 2026 | 42801611 | PubTator, text mining | PubMed |
| ERCC6 at the Transcription-Replication Interface: Integration of Transcription-Coupled Repair with Replication Stress Responses. | Int J Mol Sci | 2026 | 42653399 | PubTator, text mining | PubMed |
| Topology Resetting During Transcription-Coupled Nucleotide Excision Repair. | Int J Mol Sci | 2026 | 42653251 | PubTator, text mining | PubMed |
| Surgical correction of severe rigid equinovarus deformity in Cockayne syndrome: perioperative challenges and multidisciplinary management-a case report. | J Surg Case Rep | 2026 | 42634649 | PubTator, text mining | PubMed |
| Divergent somatic mutation patterns among human cerebellar neuron types. | Neuron | 2026 | 42575091 | PubTator, text mining | PubMed |
| Positional Effects of Single-Atom Active Sites in 1D Porphyrinic COFs on Photocatalytic CO2 Reduction. | Angew Chem Int Ed Engl | 2026 | 42531046 | PubTator, text mining | PubMed |
| Fulminant extraneural metastases in MYC-amplified Group 3 medulloblastoma: a pediatric case report. | Childs Nerv Syst | 2026 | 42399488 | PubTator, text mining | PubMed |
| Residual CSB activity explains mild UV-sensitive syndrome phenotype caused by CSB mutations. | J Invest Dermatol | 2026 | 42373067 | PubTator, text mining | PubMed |
| CRISPR/Cas9-mediated editing of ERCC6 in iPSCs: A disease model for Cockayne Syndrome type B. | Stem Cell Res | 2026 | 42349105 | PubTator, text mining | PubMed |
| Structural basis of nucleosome remodeling by Cockayne syndrome B homologue Komagataella phaffii Rad26. | Nat Commun | 2026 | 42342665 | PubTator, text mining | PubMed |
| Targeting the Mitochondrial Phenotype in Cockayne Syndrome Patient Cells: From Bioenergetic Fragility to Pharmacologic Rescue. | bioRxiv | 2026 | 42232504 | PubTator, text mining | PubMed |
| Transcription-coupled nucleotide excision repair protects against genomic instability and cell death induced by the liver toxin methyleugenol. | Cell Death Dis | 2026 | 42156710 | PubTator, text mining | PubMed |
| Design and initial characterization of a novel mini-promoter for gene therapies targeting the central nervous system. | Mol Ther Adv | 2026 | 42137269 | PubTator, text mining | PubMed |
| Inherited genetic risk factors in young-onset lung cancer. | medRxiv | 2026 | 42064918 | PubTator, text mining | PubMed |
| Genetic Markers of Tumor Multiplicity in Non-melanoma Skin Cancer: Associations of 19 SNPs in an Italian Cohort. | Dermatol Ther (Heidelb) | 2026 | 41964798 | PubTator, text mining | PubMed |
| Precisely Replicating Di-Iron Active Sites of Monooxygenases Within COFs for Dioxygen Activation Independent of External Energy Under Ambient Conditions. | Small | 2026 | 41953968 | PubTator, text mining | PubMed |
| PAF1C restores transcription after DNA damage independently of promoting histone mark deposition. | EMBO Rep | 2026 | 41951876 | PubTator, text mining | PubMed |
| Th17 cells require the DNA repair sensor xeroderma pigmentosum complementation Group C to control oxidative DNA damage in a murine model. | Nat Commun | 2026 | 41922349 | PubTator, text mining | PubMed |
| The role of transcription-coupled nucleotide excision repair (TC-NER) during mammalian forebrain development. | Dev Biol | 2026 | 41921730 | PubTator, text mining | PubMed |
| Berberine-entrapped albumin nanoparticles ameliorate chemically induced liver injury by restoring oxidative balance and autophagic-apoptotic crosstalk. | Sci Rep | 2026 | 41896259 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2074/papers